Market Overview:
The global cytomegalovirus (CMV) diagnostic market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The CMV diagnostic market is segmented on the basis of type, application, and region. On the basis of type, the CMV diagnostic market is segmented into blood and urine tests. The blood test segment dominates the CMV diagnostic market owing to its high accuracy in diagnosing CMV infections. On the basis of application, hospitals account for a major share of the global CMV diagnostic market followed by clinics and other end users such as research laboratories and pharmaceutical companies.
Product Definition:
A cytomegalovirus (CMV) diagnostic is a blood or tissue test used to detect the presence of the cytomegalovirus (CMV) virus. The test can help doctors diagnose CMV infections and determine if someone is at risk for developing complications from a CMV infection.
Blood:
The global blood market size was valued at USD 1.8 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of infectious diseases, such as HIV-AIDS, CMV infection and others are fueling the growth factor for this industry globally.
Urine:
Urine is a body fluid that is produced in the kidneys and passed from the body through the urethra. It plays an important role in maintaining hydration levels of the human body as well as helps remove toxins from it. Urine also acts as a medium to transport waste products out of cells and tissues for removal by the urinary system.
Application Insights:
The hospitals segment dominated the market in 2017 and is expected to maintain its lead over the forecast period. This can be attributed to factors such as government initiatives for improving healthcare infrastructure, increasing spending on medical devices and diagnostics, rising awareness about preventive healthcare measures, growing geriatric population base (i.e., people aged 60 years & above), and favorable reimbursement policies that encourage adoption of diagnostic technologies.
CMV is a major concern in hospitals due to high prevalence of immunocompromised patients (i.e., patients suffering from diseases such as AIDS) who are more susceptible to infection by CMV or any other virus owing to their reduced immunity.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, advanced healthcare infrastructure and high adoption rate for novel diagnostic products are some factors responsible for its large share. In addition, favorable reimbursement policies in this region are also expected to drive the demand over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing awareness about CMV infection and rising incidence of cancer due to exposure to tobacco smoke or asbestos among others reasons driving a need for early diagnosis leading it towards lucrative growth over the projected time frame.
Infection with cytomegalovirus (CMV) causes disease by inducing permanent damage which may lead toward development of malignancy or organ failure among others resulting into increased mortality rate amongst infected individuals [1].
Growth Factors:
- Increasing incidence of CMV infections: The incidence of CMV infections is increasing due to the growing population and their changing lifestyle. This is driving the demand for better diagnostic tests for early diagnosis and treatment of CMV infection.
- Growing awareness about CMV infections: There is growing awareness among people about the symptoms, transmission, and prevention of CMV infections. This is driving the demand for better diagnostic tests for early diagnosis and treatment of CMV infection.
- Technological advancements in diagnostics: There has been a significant advancement in diagnostics technology in recent years that has led to development of new and more accurate diagnostic tests for detection ofCMV infection. This is driving the demand for these new diagnostic tests, which are helping to improve accuracy and speed up diagnosis process..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cytomegalovirus (CMV) Diagnostic Market Research Report
By Type
Blood, Urine
By Application
Hospitals, Diagnostic Centers and Clinics, Others
By Companies
Abbott Laboratories, bioMérieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
173
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Cytomegalovirus (CMV) Diagnostic Market Report Segments:
The global Cytomegalovirus (CMV) Diagnostic market is segmented on the basis of:
Types
Blood, Urine
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Centers and Clinics, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- bioMérieux
- BD Biosciences
- Bio-Rad Laboratories
- Roche
- Bioneer Corp
- Siemens Healthcare
- Thermo Fisher Scientific
- Realstar Group
- Merck
- Qiagen
- Guangdong Hybribio
- Sansure Biotech
Highlights of The Cytomegalovirus (CMV) Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Blood
- Urine
- By Application:
- Hospitals
- Diagnostic Centers and Clinics
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cytomegalovirus (CMV) Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
CMV is a virus that can cause serious health problems in people of all ages. It is most commonly spread through contact with respiratory secretions, such as saliva or mucus, from an infected person. CMV can also be spread through close contact with objects or surfaces that have been contaminated with the virus. Symptoms of CMV infection vary depending on the age and health of the person infected, but may include fever, body aches and tiredness, sore throat, swollen lymph nodes (glands), diarrhea and vomiting. In severe cases, CMV infection can lead to pneumonia (a lung infection) or even death. If you think you may have contracted CMV-related illness, please see your doctor for a diagnosis.
Some of the major companies in the cytomegalovirus (cmv) diagnostic market are Abbott Laboratories, bioM©rieux, BD Biosciences, Bio-Rad Laboratories, Roche, Bioneer Corp, Siemens Healthcare, Thermo Fisher Scientific, Realstar Group, Merck, Qiagen, Guangdong Hybribio, Sansure Biotech.
The cytomegalovirus (cmv) diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cytomegalovirus (CMV) Diagnostic Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Cytomegalovirus (CMV) Diagnostic Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Cytomegalovirus (CMV) Diagnostic Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Cytomegalovirus (CMV) Diagnostic Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Cytomegalovirus (CMV) Diagnostic Market Size & Forecast, 2018-2028 4.5.1 Cytomegalovirus (CMV) Diagnostic Market Size and Y-o-Y Growth 4.5.2 Cytomegalovirus (CMV) Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
5.2.1 Blood
5.2.2 Urine
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Centers and Clinics
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cytomegalovirus (CMV) Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
9.1 Introduction
9.2 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
9.6.1 Blood
9.6.2 Urine
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Centers and Clinics
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
10.1 Introduction
10.2 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
10.6.1 Blood
10.6.2 Urine
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Centers and Clinics
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
11.6.1 Blood
11.6.2 Urine
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Centers and Clinics
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
12.1 Introduction
12.2 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
12.6.1 Blood
12.6.2 Urine
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Centers and Clinics
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Type
13.6.1 Blood
13.6.2 Urine
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Cytomegalovirus (CMV) Diagnostic Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Centers and Clinics
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cytomegalovirus (CMV) Diagnostic Market: Competitive Dashboard
14.2 Global Cytomegalovirus (CMV) Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 bioMérieux
14.3.3 BD Biosciences
14.3.4 Bio-Rad Laboratories
14.3.5 Roche
14.3.6 Bioneer Corp
14.3.7 Siemens Healthcare
14.3.8 Thermo Fisher Scientific
14.3.9 Realstar Group
14.3.10 Merck
14.3.11 Qiagen
14.3.12 Guangdong Hybribio
14.3.13 Sansure Biotech